Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Cellectar Biosciences Inc. (CLRB)

1.18   0 (0%) 11-20 09:30
Open: 1.1 Pre. Close: 1.18
High: 1.18 Low: 1.18
Volume: 306 Market Cap: 11M
Cellectar Biosciences Inc is a biopharmaceutical company. It is engaged in developing compounds for treatment and imaging of cancer. Its portfolio consists of PET imaging agents, optical imaging agents, and therapeutic agents.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.201 - 1.206 1.206 - 1.211
Low: 1.089 - 1.094 1.094 - 1.099
Close: 1.171 - 1.18 1.18 - 1.188

Technical analysis

as of: 2019-11-19 4:25:08 PM
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 1.85     One year: 2.24
Support: Support1: 1.04    Support2: 0.87
Resistance: Resistance1: 1.58    Resistance2: 1.92
Pivot: 1.30
Moving Average: MA(5): 1.11     MA(20): 1.37
MA(100): 1.94     MA(250): 2.05
MACD: MACD(12,26): -0.17     Signal(9): -0.16
Stochastic oscillator: %K(14,3): 11.90     %D(3): 7.97
RSI: RSI(14): 32.62
52-week: High: 3.75  Low: 1.04  Change(%): -45.1
Average Vol(K): 3-Month: 11530  10-Days: 9447

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
CLRB has closed above bottom band by 32.7%. Bollinger Bands are 98.7% wider than normal. The large width of the bands suggest high volatility as compared to CLRB's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Fri, 17 May 2019 02:19:10 +0000
AIMT To Face FDA Panel In Sep., FDA Lifts Hold On ADVM Trial, OTLK Jumps

Thu, 16 May 2019 18:38:11 +0000
Mid-Afternoon Market Update: KEMET Jumps On Upbeat Q4 Results; EDAP Shares Plunge

Thu, 16 May 2019 16:18:03 +0000
Mid-Day Market Update: Crude Oil Up Over 2%; Virtusa Shares Drop Following Downbeat Q4 Earnings

Thu, 16 May 2019 14:12:00 +0000
Mid-Morning Market Update: Markets Open Higher; Walmart Earnings Top Expectations

Wed, 15 May 2019 14:19:36 +0000
Mid-Morning Market Update: Markets Mostly Lower; Macy's Earnings Top Estimates

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 9.40
Shares Float (M) 7.56
% Held by Insiders 3.46
% Held by Institutions 8.07
Shares Short (K) 141
Shares Short P. Month (K)

Stock Financials

EPS -2.192
Book Value (p.s.) 1.180
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -46.5
Return on Equity (ttm) -99.9
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.378
Qtrly Earnings Growth
Operating Cash Flow (M) -11.76
Levered Free Cash Flow (M) -8.73

Stock Valuations

P/E -0.54
P/E Growth Ratio 0.07
P/CF -0.94

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2018-07-17
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.